Article Details

Vega Therapeutics launches and unveils its first-in-class antibody therapy for von ...

Retrieved on: 2022-12-06 17:40:53

Tags for this article:

Click the tags to see associated articles and topics

Vega Therapeutics launches and unveils its first-in-class antibody therapy for von .... View article details on hiswai:

Excerpt

Title: Pre-Clinical Characterization of VGA039, an Anti-Protein S Monoclonal Antibody Being Developed as a Universal Hemostatic Agent for Various ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up